Aprea Therapeutics, Inc. (APRE) - Latest Market Data

Price & Market Data

Price: $0.90

Daily Change: -$0.0303 / 3.37%

Daily Range: $0.90 - $1.00

Market Cap: $11,144,498

Daily Volume: 70,407

Performance Metrics

1 Week: 6.74%

1 Month: 6.26%

3 Months: 40.62%

6 Months: -26.83%

1 Year: -41.94%

YTD: 5.51%

About Aprea Therapeutics, Inc. (APRE)

Comprehensive market data and analysis for Aprea Therapeutics, Inc. (APRE). Current price: 0.90, daily change: -$0.0303 / 3.37%. Market cap: 11,144,498. View detailed YTD, 1-week, and 1-month performance.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.

Selected stocks

Grupo Aval Acciones y Valores S.A. (AVAL)

AMTD Digital Inc. (HKD)

Xenetic Biosciences, Inc. (XBIO)

AI Infrastructure Acquisition Corp. (AIIA-UN)